News
We’ve gone through blood, sweat, and tears to get here. This validates everything we’ve built,' Saldanha said.
InvestorsHub on MSN14h
AbbVie Shares Climb on $700 Million Licensing Deal with IGI TherapeuticsAbbVie Inc. (NYSE:ABBV) saw its stock jump 3.4% after announcing a major licensing agreement with IGI Therapeutics, securing ...
IGI Therapeutics SA, a wholly-owned subsidiary of Ichnos Glenmark Innovation (IGI)—an alliance between Glenmark Pharma and Ichnos Sciences Inc.—has signed an exclusive licensing agreement with AbbVie ...
AbbVie partners with IGI Therapeutics for ISB 2001, a potential cancer and autoimmune therapy. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback